Clinical Trial Update: Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism? [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating low dose naltrexone for pain in fibromyalgia, investigating a central mechanism of action.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Naltrexone (low-dose) (naltrexone)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Fibromyalgia | Phase 4 | Status: COMPLETED